WDNA vs. HELX
Compare and contrast key facts about WisdomTree BioRevolution Fund (WDNA) and Franklin Genomic Advancements ETF (HELX).
WDNA and HELX are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. WDNA is a passively managed fund by WisdomTree that tracks the performance of the WisdomTree BioRevolution Index. It was launched on Jun 3, 2021. HELX is an actively managed fund by Franklin Templeton. It was launched on Feb 25, 2020.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WDNA or HELX.
Key characteristics
| WDNA | HELX | |
|---|---|---|
| YTD Return | -3.67% | 3.48% |
| 1Y Return | 16.20% | 20.90% |
| 3Y Return (Ann) | -13.86% | -14.60% |
| Sharpe Ratio | 0.57 | 1.06 |
| Sortino Ratio | 0.96 | 1.58 |
| Omega Ratio | 1.11 | 1.19 |
| Calmar Ratio | 0.26 | 0.33 |
| Martin Ratio | 1.57 | 4.36 |
| Ulcer Index | 8.18% | 4.20% |
| Daily Std Dev | 22.67% | 17.31% |
| Max Drawdown | -51.90% | -56.33% |
| Current Drawdown | -41.10% | -45.72% |
Correlation
The correlation between WDNA and HELX is 0.88, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
WDNA vs. HELX - Performance Comparison
In the year-to-date period, WDNA achieves a -3.67% return, which is significantly lower than HELX's 3.48% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
WDNA vs. HELX - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is lower than HELX's 0.50% expense ratio.
Risk-Adjusted Performance
WDNA vs. HELX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
WDNA vs. HELX - Dividend Comparison
WDNA's dividend yield for the trailing twelve months is around 0.83%, while HELX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 0.83% | 0.80% | 0.37% | 0.11% | 0.00% |
HELX Franklin Genomic Advancements ETF | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% |
Drawdowns
WDNA vs. HELX - Drawdown Comparison
The maximum WDNA drawdown since its inception was -51.90%, smaller than the maximum HELX drawdown of -56.33%. Use the drawdown chart below to compare losses from any high point for WDNA and HELX. For additional features, visit the drawdowns tool.
Volatility
WDNA vs. HELX - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) and Franklin Genomic Advancements ETF (HELX) have volatilities of 4.31% and 4.46%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.